Jefferies downgrades Insmed (INSM), keeps $160 target — here’s how the stock has reacted to recent analyst actions
How INSM has reacted before
| Report | Next-day move |
|---|---|
| Jul 13, 2026 | -2.2% |
| Jun 16, 2026 | -2.0% |
| Jun 15, 2026 | -0.4% |
| Jun 11, 2026 | +5.3% |
| Jun 08, 2026 | -0.1% |
| Jun 05, 2026 | -10.2% |
| Jan 23, 2026 | -2.6% |
| Jan 21, 2026 | -4.4% |
| Jan 09, 2026 | +3.3% |
| Jan 08, 2026 | -3.3% |
| Jan 06, 2026 | -0.1% |
| Dec 19, 2025 | +5.0% |
Median absolute move 3% · higher 3 of 12 · n=12
The call
- Firm: jefferies
- Action: Downgrades
- Price target: 160.00
How $INSM moves around analyst actions
| Date | Session move |
|---|---|
| Jul 13, 2026 | -2.2% |
| Jun 16, 2026 | -2.0% |
| Jun 15, 2026 | -0.4% |
| Jun 11, 2026 | +5.3% |
| Jun 08, 2026 | -0.1% |
| Jun 05, 2026 | -10.2% |
| Jan 23, 2026 | -2.6% |
| Jan 21, 2026 | -4.4% |
| Jan 09, 2026 | +3.3% |
| Jan 08, 2026 | -3.3% |
| Jan 06, 2026 | -0.1% |
| Dec 19, 2025 | +5.0% |
Base rate (n=12):
- Median absolute move: 3.0%
- Finished higher: 3 of 12
- Biggest up day: +5.3%
- Biggest down day: -10.2%